Senolytics Plus TB Drugs Boost Survival in Infected Mice
This study suggests senolytic drugs may warrant testing as add-on therapy for tuberculosis in humans.
Tuberculosis triggers some lung cells to become senescent (zombie-like cells that won't die but cause damage). Researchers gave infected mice a senolytic cocktail of dasatinib, quercetin, and fisetin alongside standard TB treatment. The combo improved survival and reduced lung damage, especially in older mice.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchClearing Out Aging Cells Made Stem Cell Repair Work Far Better in Mice
Old, worn-out cells (called senescent cells) seem to block the body's natural repair work.
How a Cellular Calcium Glitch Speeds Up Aging in Mice
When cells lose control of their calcium balance, it sets off a chain reaction that triggers DNA damage and inflammation tied to aging.